Jäger, U. et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting. Blood Rev. 41, 1006–1048 (2020). This article by a panel of experts provides recommendations for the diagnosis and management of AIHAs.
Barcellini, W. et al. Strategies to overcome the diagnostic challenges of autoimmune hemolytic anemias. Expert Rev. Hematol. 16, 515–524 (2023).
Article CAS PubMed Google Scholar
Michel, M. Classification and therapeutic approaches in autoimmune hemolytic anemia. Expert Rev. Hematol. 4, 607–618 (2011). This review article presents the classification and the subsequent therapeutic approaches in AIHA.
Barcellini, W. et al. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood 124, 2930–2936 (2014).
Article CAS PubMed Google Scholar
Berentsen, S. & Barcellini, W. Autoimmune hemolytic anemias. N. Engl. J. Med. 385, 1407–1419 (2021).
Article CAS PubMed Google Scholar
Hansen, D. L. et al. Increasing incidence and prevalence of acquired hemolytic anemias in Denmark, 1980-2016. Clin. Epidemiol. 12, 497–508 (2020).
Maquet, J. et al. Epidemiology of autoimmune hemolytic anemia: a nationwide population-based study in France. Am. J. Hematol. 96, E291–E293 (2021).
Bylsma, L. C. et al. Occurrence, thromboembolic risk, and mortality in Danish patients with cold agglutinin disease. Blood Adv. 3, 2980–2985 (2019).
Berentsen, S. et al. Cold agglutinin disease revisited: a multinational, observational study of 232 patients. Blood 136, 480–488 (2020).
Hansen, D. L. et al. Mortality in cold agglutinin disease shows seasonal pattern. Transfusion 62, 1460–1461 (2022).
Article CAS PubMed PubMed Central Google Scholar
Barcellini, W. et al. Comparison of traditional methods and mitogen-stimulated direct antiglobulin test for detection of anti-red blood cell autoimmunity. Int. J. Hematol. 91, 763–769 (2010).
Hodgson, K. et al. Autoimmune cytopenia in chronic lymphocytic leukemia: diagnosis and treatment. Br. J. Haematol. 154, 14–22 (2011).
Zaninoni, A. et al. Detection of erythroblast antibodies in mitogen-stimulated bone marrow cultures from patients with myelodysplastic syndromes. Transfusion 56, 2037–2041 (2016).
Article CAS PubMed Google Scholar
Barcellini, W. Autoimmune complications in hematologic neoplasms. Cancers 13, 1532 (2021).
Article CAS PubMed PubMed Central Google Scholar
Naithani, R. et al. Autoimmune hemolytic anemia in India: clinico-hematological spectrum of 79 cases. Hematology 11, 73–76 (2006).
Das, S. S. et al. Clinical and serological characterization of autoimmune hemolytic anemia in a tertiary care hospital in North India. Ann. Hematol. 88, 727–732 (2009).
Kamesaki, T. Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan. Int. J. Hematol. 112, 307–315 (2020).
Article CAS PubMed Google Scholar
Kruatachue, M. S. et al. Autoimmune haemolytic anaemias in Thailand. Scand. J. Haematol. 19, 61–67 (1977).
Missoum, H. et al. Prevalence of autoimmune diseases and clinical significance of autoantibody profile: data from National Institute of Hygiene in Rabat, Morocco. Hum. Immunol. 80, 523–532 (2019).
Salawu, L. & Durosinmi, M. A. Autoimmune haemolytic anaemia: pattern of presentation and management outcome in a Nigerian population: a ten-year experience. Afr. J. Med. Med. Sci. 31, 97–100 (2002).
Hadjadj, J. et al. Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. Blood 134, 9–21 (2019).
Article CAS PubMed Google Scholar
Fattizzo, B. & Barcellini, W. Autoimmune hemolytic anemia: causes and consequences. Expert Rev. Clin. Immunol. 18, 731–745 (2022).
Article CAS PubMed Google Scholar
Tranekær, S. et al. Epidemiology of secondary warm autoimmune haemolytic anaemia — a systematic review and meta-analysis. J. Clin. Med. 10, 1244 (2022).
Roumier, M. et al. Characteristics and outcome of warm autoimmune hemolytic anemia in adults: new insights based on a single-center experience with 60 patients. Am. J. Hematol. 89, E150–E155 (2014).
Article CAS PubMed Google Scholar
Barcellini, W. et al. Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures. Expert Rev. Hematol. 13, 585–597 (2020).
Article CAS PubMed Google Scholar
Lazarian, G. et al. Autoimmune haemolytic anaemia associated with COVID-19 infection. Br. J. Haematol. 190, 29–31 (2020).
Article CAS PubMed PubMed Central Google Scholar
Stein, B. et al. Evaluation of the direct antiglobulin test (DAT) in the setting of Mycoplasma pneumoniae infection. JAMA 319, 1377–1378 (2018).
Ramagopalan, S. V. et al. Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies. BMC Med. 11, 97 (2013).
Article PubMed PubMed Central Google Scholar
Garratty, G. Drug-induced immune hemolytic anemia. Hematol. Am. Soc. Hematol. Educ. Program 2009, 73–79 (2009).
Maquet, J. et al. Drug-induced immune hemolytic anemia: detection of new signals and risk assessment in a nationwide cohort study. Blood Adv. 8, 817–826 (2024).
Article CAS PubMed Google Scholar
Delanoy, N. et al. Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study. Lancet Haematol. 6, e48–e57 (2019).
Barcellini, W. et al. Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers. Am. J. Hematol. 93, E243–E246 (2018).
Arndt, P. A. et al. Serologic findings in autoimmune hemolytic anemia associated with immunoglobulin M warm autoantibodies. Transfusion 49, 235–242 (2009).
Hansen, D. L. Survival in autoimmune hemolytic anemia remains poor, results from a nationwide cohort with 37 years of follow-up. Eur. J. Haematol. 109, 10–20 (2022).
Article CAS PubMed PubMed Central Google Scholar
Lafarge, A. et al. Prognosis of autoimmune hemolytic anemia in critically ill patients. Ann. Hematol. 98, 589–594 (2019).
留言 (0)